Pharmacy Network Verification

Our verification methodology

Every pharmacy in the Veridian network passes a five-step review before listing. We re-run verification on an annual cadence and monitor regulatory alerts in real time. The framework below exists because post-FDA enforcement on semaglutide compounding has materially tightened the line between compliant 503A patient-specific dispensing and 503B office-use outsourcing — and clinics deserve to see how that line is enforced on their behalf.

• State licensure across all 50 states. Every license is checked against the relevant state board of pharmacy database before listing.
• PCAB or ACHC accreditation on file. Pharmacy Compounding Accreditation Board or Accreditation Commission for Health Care documentation is reviewed and verified directly with the accreditor where possible.
• FDA registration status for 503B partners. Outsourcing facility registration is checked on the FDA public registry, including current cGMP compliance posture.
• Clean 483-observation history. No unresolved Form 483 observations in the prior 24 months, and no open warning letters for compounding deficiencies.
• Certificate of Analysis for every compound. Each in-network compound has a per-batch CoA on file covering potency, sterility, and endotoxin where applicable.